help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chawla, A.
Right arrow Articles by Lazar, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chawla, A.
Right arrow Articles by Lazar, M. A.

Endocrinology, Vol 135, 798-800, Copyright © 1994 by Endocrine Society

ARTICLES

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose- predominant expression and induction early in adipocyte differentiation

A Chawla, EJ Schwarz, DD Dimaculangan and MA Lazar
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

Activators of peroxisome proliferator activated receptor (PPAR) regulate fatty acid metabolism and can induce adipocyte differentiation. We show here that the gamma subtype of PPAR is expressed at high levels in adipose tissue in contrast to a variety of other tissues, where little gene expression was noted. In addition, PPAR gamma is present at low levels in 3T3-L1 preadipocytes and is induced dramatically during adipocyte conversion using either normal differentiating conditions (fetal calf serum, dexamethasone, isobutyl- methylxanthine, and insulin) or the PPAR activator, WY-14,643. Thus PPAR gamma may be important for adipose cell development and function.


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
G. Tuteja, S. T. Jensen, P. White, and K. H. Kaestner
Cis-regulatory modules in the mammalian liver: composition depends on strength of Foxa2 consensus site
Nucleic Acids Res., July 1, 2008; 36(12): 4149 - 4157.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Wang and M. A. Lazar
Bifunctional Role of Rev-erb{alpha} in Adipocyte Differentiation
Mol. Cell. Biol., April 1, 2008; 28(7): 2213 - 2220.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Kim, M. Sato, Q. Li, J. P. Lydon, F. J. DeMayo, I. C. Bagchi, and M. K. Bagchi
Peroxisome Proliferator-Activated Receptor {gamma} Is a Target of Progesterone Regulation in the Preovulatory Follicles and Controls Ovulation in Mice
Mol. Cell. Biol., March 1, 2008; 28(5): 1770 - 1782.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Miyawaki, S. Kamei, K. Sakayama, H. Yamamoto, and H. Masuno
4-Tert-Octylphenol Regulates the Differentiation of C3H10T1/2 Cells into Osteoblast and Adipocyte Lineages
Toxicol. Sci., March 1, 2008; 102(1): 82 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
Y. H. Kim and H. J. Han
High-Glucose-Induced Prostaglandin E2 and Peroxisome Proliferator-Activated Receptor {delta} Promote Mouse Embryonic Stem Cell Proliferation
Stem Cells, March 1, 2008; 26(3): 745 - 755.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. N. Johnstone, P. S. Mongroo, A. S. Rich, M. Schupp, M. J. Bowser, A. S. deLemos, J. W. Tobias, Y. Liu, G. E. Hannigan, and A. K. Rustgi
Parvin- Inhibits Breast Cancer Tumorigenicity and Promotes CDK9-Mediated Peroxisome Proliferator-Activated Receptor Gamma 1 Phosphorylation
Mol. Cell. Biol., January 15, 2008; 28(2): 687 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
A. C. Grant, G. Ortiz-Colon, M. E. Doumit, and D. D. Buskirk
Optimization of in vitro conditions for bovine subcutaneous and intramuscular preadipocyte differentiation
J Anim Sci, January 1, 2008; 86(1): 73 - 82.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. S. Muhlhausler, J. A. Duffield, and I. C. McMillen
Increased Maternal Nutrition Increases Leptin Expression in Perirenal and Subcutaneous Adipose Tissue in the Postnatal Lamb
Endocrinology, December 1, 2007; 148(12): 6157 - 6163.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. I. Anghel, E. Bedu, C. D. Vivier, P. Descombes, B. Desvergne, and W. Wahli
Adipose Tissue Integrity as a Prerequisite for Systemic Energy Balance: A CRITICAL ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {gamma}
J. Biol. Chem., October 12, 2007; 282(41): 29946 - 29957.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
N. B. Mettu, T. B. Stanley, M. A. Dwyer, M. S. Jansen, J. E. Allen, J. M. Hall, and D. P. McDonnell
The Nuclear Receptor-Coactivator Interaction Surface as a Target for Peptide Antagonists of the Peroxisome Proliferator-Activated Receptors
Mol. Endocrinol., October 1, 2007; 21(10): 2361 - 2377.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Y. Han, S. Subramanian, C. K. Chan, M. Omer, T. Chiba, T. N. Wight, and A. Chait
Adipocyte-Derived Serum Amyloid A3 and Hyaluronan Play a Role in Monocyte Recruitment and Adhesion
Diabetes, September 1, 2007; 56(9): 2260 - 2273.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
B. Li, H. N. Zerby, and K. Lee
Heart fatty acid binding protein is upregulated during porcine adipocyte development
J Anim Sci, July 1, 2007; 85(7): 1651 - 1659.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Schupp, J. C. Curtin, R. J. Kim, A. N. Billin, and M. A. Lazar
A Widely Used Retinoic Acid Receptor Antagonist Induces Peroxisome Proliferator-Activated Receptor-{gamma} Activity
Mol. Pharmacol., May 1, 2007; 71(5): 1251 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. D. Brown and J. Plutzky
Peroxisome Proliferator Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
Circulation, January 30, 2007; 115(4): 518 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
L. Michalik, J. Auwerx, J. P. Berger, V. K. Chatterjee, C. K. Glass, F. J. Gonzalez, P. A. Grimaldi, T. Kadowaki, M. A. Lazar, S. O'Rahilly, et al.
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 726 - 741.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Chen, B. M. Necela, W. Su, M. Yanagisawa, P. Z. Anastasiadis, A. P. Fields, and E. A. Thompson
Peroxisome Proliferator-activated Receptor {gamma} Promotes Epithelial to Mesenchymal Transformation by Rho GTPase-dependent Activation of ERK1/2
J. Biol. Chem., August 25, 2006; 281(34): 24575 - 24587.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. J. Lee, E. K. Yang, and S. G. Kim
Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoic Acid X Receptor {alpha} Represses the TGFbeta1 Gene via PTEN-Mediated p70 Ribosomal S6 Kinase-1 Inhibition: Role for Zf9 Dephosphorylation
Mol. Pharmacol., July 1, 2006; 70(1): 415 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. J. Giordano, A. Y.M. Au, R. Kuick, D. G. Thomas, D. R. Rhodes, K. G. Wilhelm Jr., M. Vinco, D. E. Misek, D. Sanders, Z. Zhu, et al.
Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation.
Clin. Cancer Res., April 1, 2006; 12(7): 1983 - 1993.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
N. E. Wolins, B. K. Quaynor, J. R. Skinner, A. Tzekov, C. Park, K. Choi, and P. E. Bickel
OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis
J. Lipid Res., February 1, 2006; 47(2): 450 - 460.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. Blaschke, Y. Takata, E. Caglayan, R. E. Law, and W. A. Hsueh
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 28 - 40.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Ando, H. Yanagihara, Y. Hayashi, Y. Obi, S. Tsuruoka, T. Takamura, S. Kaneko, and A. Fujimura
Rhythmic Messenger Ribonucleic Acid Expression of Clock Genes and Adipocytokines in Mouse Visceral Adipose Tissue
Endocrinology, December 1, 2005; 146(12): 5631 - 5636.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
B. Brachvogel, H. Moch, F. Pausch, U. Schlotzer-Schrehardt, C. Hofmann, R. Hallmann, K. von der Mark, T. Winkler, and E. Poschl
Perivascular cells expressing annexin A5 define a novel mesenchymal stem cell-like population with the capacity to differentiate into multiple mesenchymal lineages
Development, June 1, 2005; 132(11): 2657 - 2668.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
H.-P. Guan, T. Ishizuka, P. C. Chui, M. Lehrke, and M. A. Lazar
Corepressors selectively control the transcriptional activity of PPAR{gamma} in adipocytes
Genes & Dev., February 15, 2005; 19(4): 453 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. Knouff and J. Auwerx
Peroxisome Proliferator-Activated Receptor-{gamma} Calls for Activation in Moderation: Lessons from Genetics and Pharmacology
Endocr. Rev., December 1, 2004; 25(6): 899 - 918.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
I. E. Camacho, L. Serneels, K. Spittaels, P. Merchiers, D. Dominguez, and B. De Strooper
Peroxisome Proliferator-Activated Receptor {gamma} Induces a Clearance Mechanism for the Amyloid-{beta} Peptide
J. Neurosci., December 1, 2004; 24(48): 10908 - 10917.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
V. Subbarayan, A. L. Sabichi, J. Kim, N. Llansa, C. J. Logothetis, S. M. Lippman, and D. G. Menter
Differential Peroxisome Proliferator-Activated Receptor-{gamma} Isoform Expression and Agonist Effects in Normal and Malignant Prostate Cells
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1710 - 1716.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Matsui, Y. Terauchi, N. Kubota, I. Takamoto, K. Eto, T. Yamashita, K. Komeda, T. Yamauchi, J. Kamon, S. Kita, et al.
Pioglitazone Reduces Islet Triglyceride Content and Restores Impaired Glucose-Stimulated Insulin Secretion in Heterozygous Peroxisome Proliferator-Activated Receptor-{gamma}-Deficient Mice on a High-Fat Diet
Diabetes, November 1, 2004; 53(11): 2844 - 2854.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. T. Coughlan, M. Permezel, H. M. Georgiou, and G. E. Rice
Repression of Oxidant-Induced Nuclear Factor-{kappa}B Activity Mediates Placental Cytokine Responses in Gestational Diabetes
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3585 - 3594.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Y. Park, I. J. Cho, and S. G. Kim
Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Heterodimer
Cancer Res., May 15, 2004; 64(10): 3701 - 3713.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Zayzafoon, W. E. Gathings, and J. M. McDonald
Modeled Microgravity Inhibits Osteogenic Differentiation of Human Mesenchymal Stem Cells and Increases Adipogenesis
Endocrinology, May 1, 2004; 145(5): 2421 - 2432.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Sekiya, J.-i. Osuga, H. Okazaki, N. Yahagi, K. Harada, W.-J. Shen, Y. Tamura, S. Tomita, Y. Iizuka, K. Ohashi, et al.
Absence of Hormone-sensitive Lipase Inhibits Obesity and Adipogenesis in Lepob/ob Mice
J. Biol. Chem., April 9, 2004; 279(15): 15084 - 15090.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
W. A. Hsueh and D. Bruemmer
Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease
Hypertension, February 1, 2004; 43(2): 297 - 305.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Asada, S. Sasaki, T. Suda, K. Chida, and H. Nakamura
Antiinflammatory Roles of Peroxisome Proliferator-activated Receptor {gamma} in Human Alveolar Macrophages
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 195 - 200.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Bildirici, C.-R. Roh, W. T. Schaiff, B. M. Lewkowski, D. M. Nelson, and Y. Sadovsky
The Lipid Droplet-Associated Protein Adipophilin Is Expressed in Human Trophoblasts and Is Regulated by Peroxisomal Proliferator-Activated Receptor-{gamma}/Retinoid X Receptor
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6056 - 6062.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Dowell, T. C. Otto, S. Adi, and M. D. Lane
Convergence of Peroxisome Proliferator-activated Receptor {gamma} and Foxo1 Signaling Pathways
J. Biol. Chem., November 14, 2003; 278(46): 45485 - 45491.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Koumas, T. J. Smith, S. Feldon, N. Blumberg, and R. P. Phipps
Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes
Am. J. Pathol., October 1, 2003; 163(4): 1291 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Gavrilova, M. Haluzik, K. Matsusue, J. J. Cutson, L. Johnson, K. R. Dietz, C. J. Nicol, C. Vinson, F. J. Gonzalez, and M. L. Reitman
Liver Peroxisome Proliferator-activated Receptor {gamma} Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass
J. Biol. Chem., September 5, 2003; 278(36): 34268 - 34276.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. Aoun, J. W. Simpkins, and N. Agarwal
Role of PPAR-{gamma} Ligands In Neuroprotection against Glutamate-Induced Cytotoxicity in Retinal Ganglion Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2999 - 3004.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Giusti, C. Verdumo, M. Suter, R. C. Gaillard, P. Burckhardt, and F. Pralong
Expression of Peroxisome Proliferator-Activated Receptor-{gamma}1 and Peroxisome Proliferator-Activated Receptor-{gamma}2 in Visceral and Subcutaneous Adipose Tissue of Obese Women
Diabetes, July 1, 2003; 52(7): 1673 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Ameshima, H. Golpon, C. D. Cool, D. Chan, R. W. Vandivier, S. J. Gardai, M. Wick, R. A. Nemenoff, M. W. Geraci, and N. F. Voelkel
Peroxisome Proliferator-Activated Receptor Gamma (PPAR{gamma}) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth
Circ. Res., May 30, 2003; 92(10): 1162 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Dello Russo, V. Gavrilyuk, G. Weinberg, A. Almeida, J. P. Bolanos, J. Palmer, D. Pelligrino, E. Galea, and D. L. Feinstein
Peroxisome Proliferator-activated Receptor gamma Thiazolidinedione Agonists Increase Glucose Metabolism in Astrocytes
J. Biol. Chem., February 14, 2003; 278(8): 5828 - 5836.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
O. Seda, L. Kazdova, D. Krenova, and V. Kren
Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain
Physiol Genomics, January 15, 2003; 12(2): 73 - 78.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Kajita, T. Ishizuka, T. Mune, A. Miura, M. Ishizawa, Y. Kanoh, Y. Kawai, Y. Natsume, and K. Yasuda
Dehydroepiandrosterone Down-Regulates the Expression of Peroxisome Proliferator-Activated Receptor {gamma} in Adipocytes
Endocrinology, January 1, 2003; 144(1): 253 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Yeh, M.-Y. Tsai, Q. Xu, X.-M. Mu, H. Lardy, K.-E. Huang, H. Lin, S.-D. Yeh, S. Altuwaijri, X. Zhou, et al.
Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues
PNAS, October 15, 2002; 99(21): 13498 - 13503.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. P. Marso
Optimizing the diabetic formulary: beyond aspirin and insulin
J. Am. Coll. Cardiol., August 21, 2002; 40(4): 652 - 661.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
K. D. Childs, D. W. Goad, M. F. Allan, D. Pomp, C. Krehbiel, R. D. Geisert, J. B. Morgan, and J. R. Malayer
Differential expression of NAT1 translational repressor during development of bovine intramuscular adipocytes
Physiol Genomics, August 14, 2002; 10(2): 49 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N.-S. Tan, N. S. Shaw, N. Vinckenbosch, P. Liu, R. Yasmin, B. Desvergne, W. Wahli, and N. Noy
Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription
Mol. Cell. Biol., July 15, 2002; 22(14): 5114 - 5127.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Cui, K. Miyoshi, E. Claudio, U. K. Siebenlist, F. J. Gonzalez, J. Flaws, K.-U. Wagner, and L. Hennighausen
Loss of the Peroxisome Proliferation-activated Receptor gamma (PPARgamma ) Does Not Affect Mammary Development and Propensity for Tumor Formation but Leads to Reduced Fertility
J. Biol. Chem., May 10, 2002; 277(20): 17830 - 17835.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Li and M. A. Lazar
Differential Gene Regulation by PPAR{gamma} Agonist and Constitutively Active PPAR{gamma}2
Mol. Endocrinol., May 1, 2002; 16(5): 1040 - 1048.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. L. Schild, W. T. Schaiff, M. G. Carlson, E. J. Cronbach, D. M. Nelson, and Y. Sadovsky
The Activity of PPAR{gamma} in Primary Human Trophoblasts Is Enhanced by Oxidized Lipids
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1105 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
R. B. Clark
The role of PPARs in inflammation and immunity
J. Leukoc. Biol., March 1, 2002; 71(3): 388 - 400.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
S. M. Rangwala and M. A. Lazar
The Dawn of the SPPARMs?
Sci. Signal., February 26, 2002; 2002(121): pe9 - pe9.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Y. Oyama, N. Akuzawa, R. Nagai, and M. Kurabayashi
PPAR{gamma} Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 Cells
Circ. Res., February 22, 2002; 90(3): 348 - 355.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. E. Floyd and J. M. Stephens
Interferon-gamma -mediated Activation and Ubiquitin-Proteasome-dependent Degradation of PPARgamma in Adipocytes
J. Biol. Chem., February 1, 2002; 277(6): 4062 - 4068.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. A. Lazar
Becoming fat
Genes & Dev., January 1, 2002; 16(1): 1 - 5.
[Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. M. David, M. R. Moore, D. C. Finney, and D. Guest
Reversibility of the Chronic Effects of Di(2-ethylhexyl)phthalate
Toxicol Pathol, June 1, 2001; 29(4): 430 - 439.
[Abstract] [PDF]

Home page
 DiabetesHome page
M. Caron, M. Auclair, C. Vigouroux, M. Glorian, C. Forest, and J. Capeau
The HIV Protease Inhibitor Indinavir Impairs Sterol Regulatory Element-Binding Protein-1 Intranuclear Localization, Inhibits Preadipocyte Differentiation, and Induces Insulin Resistance
Diabetes, June 1, 2001; 50(6): 1378 - 1388.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Ohta, T. Endo, K. Haraguchi, J. M. Hershman, and T. Onaya
Ligands for Peroxisome Proliferator-Activated Receptor {{gamma}} Inhibit Growth and Induce Apoptosis of Human Papillary Thyroid Carcinoma Cells
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2170 - 2177.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
E. C. Person, L. L. Waite, R. N. Taylor, and T. S. Scanlan
Albumin Regulates Induction of Peroxisome Proliferator-Activated Receptor-{{gamma}} (PPAR{{gamma}}) by 15-Deoxy-{{Delta}}12-14-Prostaglandin J2 in Vitro and May Be an Important Regulator of PPAR{{gamma}} Function in Vivo
Endocrinology, February 1, 2001; 142(2): 551 - 556.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. M. Steppan, E. J. Brown, C. M. Wright, S. Bhat, R. R. Banerjee, C. Y. Dai, G. H. Enders, D. G. Silberg, X. Wen, G. D. Wu, et al.
A family of tissue-specific resistin-like molecules
PNAS, January 16, 2001; 98(2): 502 - 506.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. T